A Novel Way to Treat Adults With Moderate-To-Severe Plaque Psoriasis – A BMS-sponsored episode

Despite the availability of many treatment options for moderate-to-severe plaque psoriasis, there is still a need for additional therapies. Hear from Ryan Moslin, Principal Scientist, BMS, who suffers from moderate-to-severe plaque psoriasis, and Tom Scharnitz, M.D., the Senior Director and US Medical Lead for Dermatology, BMS, as they provide the science and research behind an oral treatment for moderate-to-severe plaque psoriasis.

Please see Important Safety Information and U.S. Full Prescribing Information including Medication Guide for SOTYKTU, indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

This PsoundBytes™ episode is sponsored by Bristol-Myers Squibb.